Comparison of intravaginal 6.5 mg (0.50%) prasterone, 0.3 mg conjugated estrogens and 10 mu g estradiol on symptoms of vulvovaginal atrophy Review

authors

publication date

  • November 1, 2017

webpage

published in

keywords

  • Conjugated estrogens
  • Dehydroepiandrosterone
  • Dyspareunia
  • Estradiol
  • Intravaginal
  • Prasterone
  • Vaginal atrophy
  • Vaginal dryness

start page

  • 1

end page

  • 8

volume

  • 174